Update: Annual General Meeting of Shareholders of AB Linas Agro Group is convened on October 29, 2021
Update: by the decision of the Board of AB Linas Agro Group, adopted on 8 October, 2021, the Annual General Meeting of Shareholders agenda clause No. 7 is revised, documents supplementing the agenda of the Meeting added
Hereby we announce the Annual General Meeting of Shareholders (hereinafter – the Meeting) of AB Linas Agro Group, registered address Smėlynės St. 2C, Panevėžys, Lithuania, code 148030011, (hereinafter – the Company) is convened.
With continued uncertainty around the status of the COVID-19 pandemic and being unable to accurately predict further decisions and restrictions, we strongly recommend all shareholders to participate in the Meeting by taking the opportunity to vote in advance.
If on the day of the Meeting restrictions related to pandemic including the quarantinewill be valid in the territory of the Republic of Lithuania or Vilnius city municipality and events or gatherings organized in closed areas will be banned or restricted, or any other restrictions are imposed, the participation in the Meeting would be possible only by voting in writing in advance by filling in the General Voting Ballot.
The date, time and venue of the Meeting – 29 October, 2021 at 10.00 a.m., Radisson Blu Royal Astorija Hotel, Symphony Hall (Didžioji St. 35/2, Vilnius, Lithuania).
Accounting day of the Meeting is 22 October, 2021. Only the persons who are the shareholders of the Company at the end of the Accounting day of the Meeting shall have the right to attend and vote at the Meeting.
The Rights Accounting day is 16 November, 2021. Only the persons who are the shareholders of the Company at the end of the Rights Accounting day shall have proprietary rights.
On the day the Meeting is convened the total number of the Company's shares is 158,940,398, and the number of shares granting voting rights is 158,172,426. The own shares in amount of 767,972 acquired by the Company do not grant voting rights. The ISIN code of the Company's shares is LT0000128092.
Agenda of the Meeting:
- Presentation of the Company’s Audit Committee Activity Report.
- Presentation of the independent auditors’ report.
- Presentation of the Consolidated Annual Report of the Company for the financial year 2020/2021.
- Approval of Company’s Remuneration Report.
- Approval of the consolidated and the Company‘s set of financial statements for the financial year ended 30 June, 2021.
- Approval of the Distribution of the Company‘s Profit (Loss).
- Election of the audit company to audit Company‘s financial statements and establishment of the payment for the services.
- Increase of the Company‘s share capital;
- Revocation of the pre-emption right of all shareholders of the Company to acquire the newly issued shares in order to grant shares of the Company free of charge to the employees and/or members of the Company’s corporate bodies;
- Approval of a new wording of the Articles of Association of the Company;
- Approval of terms and conditions regarding the payment of the subscribed shares;
- Change of the registered office of the Company.
Initiator of convening of the Meeting is the Board of the Company.
The Meeting is convened by the decisions of the Board of the Company, adopted on 7 October, 2021 and 8 October, 2021.
Registration of the Shareholders of the Company starts: 29 October, 2021 at 9.15 a.m.
Registration of the Shareholders of the Company ends: 29 October, 2021 at 9.55 a.m.
The Company does not provide possibility to attend and vote at the Meeting through electronic means of communication.
Persons who at the end of the Accounting day of the Meeting will be shareholders of the Company, or their authorized persons, or persons with whom an agreement on the disposal of the voting right has been concluded, will have the right to personally participate and vote at the meeting.
A person attending the Meeting must submit a person’s identification document. A person who is not a shareholder must additionally produce a document confirming his/her right to vote at the Meeting.
Each shareholder shall have a right in the manner established by the Laws to authorize natural or legal person on his/her behalf to attend and vote at the Meeting. At the Meeting, an authorized person shall have the same rights as the shareholder represented by him/her, unless otherwise specified in the issued power of attorney. A power of attorney issued abroad must be translated into Lithuanian and legalized in the manner established by the Laws. The Company does not require a special form of power of attorney.
The agenda of the Meeting may be supplemented by initiative of the shareholders holding shares carrying at least 1/20 of all the votes. The drafts of proposed decisions on proposed issues or, if the decision shall not be adopted, explanation on each proposed issue of the agenda of the Meeting shall be presented alongside with the proposal to supplement the agenda of the Meeting. The proposal to supplement the agenda shall be submitted in writing by sending it by registered mail to AB Linas Agro Group at the address Subačiaus St. 5, Vilnius, Lithuania or by e-mail firstname.lastname@example.org. The agenda of the Meeting shall be supplemented if the proposal is received not later than 14 days before the Meeting.
The shareholders who own shares carrying at least 1/20 of all the votes shall have the right at any time before the Meeting or during the Meeting to propose new draft decisions on the issue already included or to be included in to the agenda of the Meeting. The proposed draft decisions must be presented in writing by sending them by registered mail to AB Linas Agro Group at the address Subačiaus St. 5, Vilnius, Lithuania or by e-mail email@example.com. The shareholders shall also be entitled to propose draft decisions on the agenda issues of the Meeting in writing during the Meeting.
The shareholders shall have the right to present questions related to the agenda issues of the Meeting to the Company. The questions in writing can be presented not later than 3 working days before the Meeting, by providing the shareholder’s personal identification number and consent to process personal data by registered mail to AB Linas Agro Group at the address Subačiaus St. 5, Vilnius, Lithuania. Responses of general character shall be posted on the Company’s website www.linasagrogroup.lt. The Company will not respond to the shareholder personally if the respective information is posted on the Company’s website.
A shareholder or a person authorized by him/her shall have right to vote in writing in advance by filling in the General Voting Ballot. Upon a written request of the shareholder holding the voting right, the Company shall send the General Voting Ballot by registered mail not later than 10 days before the Meeting. The General Voting Ballot also will be provided on the Company’s website www.linasagrogroup.lt. The filled in General Voting Ballot must be signed by the shareholder or by the person authorized by him/her. If the person who is authorized by the shareholder is voting, the document confirming the right to vote must be attached to the filled in General Voting Ballot. The document confirming the voting right must be in Lithuanian or translated into Lithuanian by authorized translator and his/her signature must be confirmed by notarius. The filled in General Voting Ballot and the document confirming the voting right must be submitted to the Company in written form not later than the last working day before the Meeting, by sending it by registered mail to AB Linas Agro Group at the address Subačiaus St. 5, Vilnius, Lithuania or personally to the Company.
The shareholders can familiarize themselves with the documents, related to the agenda of the Meeting, draft decisions on each issue of the agenda, documents to be submitted to the Meeting, and other information regarding execution of the shareholders rights, in the website of the Company www.linasagrogroup.lt, also on arrival at Subačiaus St. 5, Vilnius, Lithuania during business days at time agreed in advance by phone No +370 45 507 303 only.
AB Linas Agro Group Activity Report of the Company's Audit Committee for the financial year 2020/2021
A set of annual statements of AB Linas Agro Group for the financial year 2020/2021 with the independent auditor's report
AB Linas Agro Group Remuneration Report for the financial year 2020/2021
The new wording of the Articles of Association of AB Linas Agro Group
Draft resolutions of the General Meeting of Shareholders
General voting ballot
Chairman of the Board Darius Zubas
Please contact for further information:
Mažvydas Šileika, Finance Director of AB Linas Agro Group
Mob. +370 619 19 403
- LNA_2020-2021FY_Remuneration Report
- LNA_draft decisions ASHM
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes27.10.2021 22:00:00 CEST | Press release
The LEGEND trial is a proof-of-concept Phase IIa clinical trial to evaluate the safety and efficacy of lanifibranor in combination with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance®1) in patients with non-alcoholic steatohepatitis (NASH) and type 2 diabetes (T2D)The trial will be conducted in several sites in the United States and Europe with a treatment duration of 24 weeks, and a total enrollment target of 63 patients with T2D and non-cirrhotic NASHThe initiation of the trial is planned for H1 2022 and the publication of topline results is expected for H2 2023 Daix (France), Long Island City (New York, United States), October 27, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, mucopolysaccharidoses (MPS) and other diseases with significant unmet medical needs, today announced the design of a proof-of-concept Phase IIa co
Johnson & Johnson partially converts its convertible loan27.10.2021 19:03:46 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 27, 2021 Idorsia Ltd (SIX: IDIA) today announced that Cilag Holding AG, an indirect subsidiary of Johnson & Johnson, notified Idorsia that it will convert a second tranche of the remaining principal amount of CHF 445 million convertible loan, such that CHF 110 million will be converted into 9.6 million shares of Idorsia. As a result of the conversion, Idorsia will issue 9’581’882 new shares and Idorsia share capital will increase from CHF 8’364’748.55 to CHF 8’843’842.65, divided into 176’876’853 Idorsia shares. As a result of conversion of the second tranche of the convertible loan, Cilag Holding AG will hold 5.7% of Idorsia’s issued share capital. Following conversion, the remaining principal amount of the convertible loan will be CHF 335 million, convertible into 29.1 million shares of Idorsia. Notes to the editor About the convertible loan On June 15, 2017, Cilag Holding AG (“Cilag”) provided a loan of CHF
AMG Advanced Metallurgical Group N.V. Reports Third Quarter 2021 Results27.10.2021 18:00:00 CEST | Press release
Coronavirus Update Active cases at AMG remain at a very low level. We continue to apply all safety measures at our disposal with the highest degree of attention in order to ensure our employees are working in the lowest risk environment possible. Strategic Highlights The construction of AMG Vanadium’s second spent catalyst recycling facility in Zanesville, Ohio, a $325 million investment and AMG’s largest capital project to date, is proceeding as planned. Commissioning starts in the first quarter of 2022 and the plant is forecast to achieve full run rate capacity in the fourth quarter of 2022.Spodumene 1+ will increase Brazil’s spodumene production by 40,000 tons. The project is currently in detailed engineering and commissioning is planned to start in the second quarter of 2023.AMG’s Supervisory Board approved the construction of the first module of a battery grade lithium hydroxide upgrader in Bitterfeld, Germany in its meeting on October 27, 2021. The total expenditure of $120 milli
The world’s first fully accessible art depot opens its doors in 10 days27.10.2021 16:36:25 CEST | Press release
Depot Boijmans Van Beuningen in Rotterdam Rotterdam, Oct. 27, 2021 (GLOBE NEWSWIRE) -- The world’s first fully accessible art depot opens its doors in 10 days Depot Boijmans Van Beuningen is set to open its doors in 10 days – on 6 November 2021 – making the entire internationally renowned art collection of Museum Boijmans Van Beuningen accessible to the public. Museums around the world usually display just 6 to 10 percent of their collections; the rest lies in storage. Depot Boijmans Van Beuningen breaks with this hidden tradition and makes all the invisible artworks visible – a world first. In the iconic, mirrored art depot designed by MVRDV the museum’s 151,000 artefacts are placed at the heart of the city. The depot’s ovoid shape makes it a building that is open in every direction. The bowl-like form means that the footprint is small and the rooftop area as expansive as possible. The fully mirrored edifice consists of 6,609 square metres of glass, divided into 1,664 mirror panels, w
Workday presenterar en djupare digital upplevelse för anställda med Workday Everywhere27.10.2021 16:24:43 CEST | Pressemelding
Obegränsad upplevelse etablerar Workday inom populära arbetsområden och företagsappar för att hjälpa anställda att hålla sig engagerade, produktiva och uppkopplade. STOCKHOLM, Sweden, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Workday, Inc. (NASDAQ: WDAY), en ledande leverantör inom molnlösningar för företag inom ekonomi och HR, tillkännagav idag lanseringen av Workday Everywhere, paketerade anslutningar som tar uppgifter och insikter från Workday direkt till digitala arbetsmiljöer för att hjälpa organisationer att förbättra anställdas upplevelser. Med Workday Everywhere kan anställda snabbt få tillgång till Workday i sitt arbetsflöde utan att växla mellan olika applikationer. Arbetsgivare kan använda Workday Everywhere för att leverera en enkel och uppkopplad upplevelse som förbättrar medarbetarnas produktivitet och engagemang. Workday Everywhere är det senaste erbjudandet från Workday för medarbetare upplevelser och stödjer en pågående satsning för att öka engagemanget med en öppen och frikti
Aspo’s financial reporting in 202227.10.2021 12:00:00 CEST | Press release
Aspo Plc Stock Exchange Release October 27, 2021 at 1 p.m. Aspo’s financial reporting in 2022 In 2022, Aspo Plc will publish its financial statement release, half year financial report and two interim reports as follows: - financial statement release for 2021 on Wednesday, February 16, 2022 - interim report for January-March on Wednesday, May 4, 2022 - half year financial report for January-June on Wednesday, August 10, 2022 - interim report for January-September on Wednesday, November 2, 2022 The Financial Statements and Sustainability Report 2021 will be published on the company’s website during week 10. Aspo’s Annual Shareholders’ Meeting is scheduled for Wednesday, April 6, 2022, in Helsinki, Finland. The Board of Directors will give a separate notice of the Annual Shareholders’ Meeting later. Possible requests from shareholders to include matters on the agenda of Aspo’s 2021 Annual Shareholders’ Meeting shall be sent to Aspo’s Board of Directors not later than February 9, 2022. Th
Correction: RESULT RIKSBANK PURCHASES OF CORPORATE BONDS27.10.2021 11:35:12 CEST | Press release
AuctionResult of auctionAuction date2021-10-27NameHeimstaden Bostad ABIsinXS2259781230Coupon, spread1.368Maturity2025-02-25Tendered volume, SEK mln30 +/- 30Offered volume, SEK mln-Volume bought, SEK mln-Number of bids-Number of accepted bids-Average yield, DM-Lowest accepted yield, DM-Highest yield, DM-Accepted at lowest yield, %- AuctionResult of auctionAuction date2021-10-27NameCastellum ABIsinSE0012675916Coupon, spread1.545Maturity2025-11-27Tendered volume, SEK mln30 +/- 30Offered volume, SEK mln6Volume bought, SEK mln6Number of bids1Number of accepted bids1Average yield, DM1.400%Lowest accepted yield, DM1.400%Highest yield, DM1.400%Accepted at lowest yield, %100.00 AuctionResult of auctionAuction date2021-10-27NameCastellum ABIsinSE0011062827Coupon, spread1.650Maturity2023-05-17Tendered volume, SEK mln30 +/- 30Offered volume, SEK mln-Volume bought, SEK mln-Number of bids-Number of accepted bids-Average yield, DM-Lowest accepted yield, DM-Highest yield, DM-Accepted at lowest yield,